Elemind has secured a significant $12M in seed funding, bolstering its mission to pioneer AI-driven solutions in the neurotech health arena. This Cambridge, MA-based company's financial support is drawn from a diverse investor base including Village Global, LDV Partners, and notable founders from Skype to Boston Scientific. Elemind plans to channel these funds into advancing their innovative technologies aimed at transforming neurological healthcare.